BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 5, 2004
View Archived Issues
First patient enrolled in trial of dendritic cell vaccine for melanoma
Read More
Extended phase I trial of INT for diabetes
Read More
CTX granted for phase IIa trial of ATL-104 for mucositis
Read More
Positive proof of concept results for SUDCA
Read More
Chiron licenses Coley's VaxImmune
Read More
Strategic alliance and IND plans for new DNA-based HIV vaccine
Read More
Dynogen to develop Mitsubishi neurological compound for IBS
Read More
Novartis files sNDA for new indication for Diovan
Read More
Wex files CTA for pivotal Tectin trial
Read More
Methylphenidate improves fatigue and physical well being in advanced cancer patients
Read More
PGN-0052 advances to phase II
Read More
IL-18 vaccination as a potential strategy for treating lupus
Read More
HEP DART 2003 meeting highlights: Phase Ib data presented for isatoribine
Read More
Merimepodib enhances the anti-HCV activity of PEG-IFN and ribavirin
Read More
DMC recommends continuation of phase III Oncophage trial
Read More
Cardiome submits oxypurinol NDA
Read More
ICA-69673 set to enter phase I
Read More
Nastech submits abbreviated NDA for Calcitonin-Salmon nasal spray
Read More
Preclinical milestone achieved in Neurogen/Aventis collaboration
Read More
Abbott and Protein Design Labs enter IL-12 licensing agreement
Read More
Novel anti-Helicobacter pylori agents developed by Shionogi researchers
Read More
New anti-herpes virus compounds reported by Yamanouchi and Rational Drug Design
Read More
Banyu team reports the preparation and use of new ORL1 antagonists
Read More
Bislactone-based acetyl-CoA carboxylase inhibitors newly identified at Ajinomoto
Read More
New 5-HT6 modulators, their preparation and use described in Roche patent
Read More
Insight into the mechanism of the antilipemic effects of FR-218944
Read More
Improved profile of TRA-418 possibly due to dual activity
Read More